Partnering with us
Our partners’ satisfaction drives everything we do. We understand pharmaceutical players’ need to innovate so that patients around the world can enjoy improved access to drugs.
We offer long-term, strategic partnerships at Doppel, providing high-quality products and services at competitive prices. As a leading EU-based CDMO, we work collaboratively and efficiently to serve innovative pharmaceutical and biotech companies. Our assistance increases the pace and depth of their product portfolio and provides patients with quicker access to treatment.
We aim to offer a responsive and entrepreneurial approach to satisfy diverse needs, whether NCE, repurposed drugs (or 505b2), OTC, GX, or nutraceutical product development, from non-GMP feasibility formulation to commercial finished product manufacturing (including aggregation and serialisation, where needed).
Doppel is a fully integrated and globally positioned CDMO; our world-class R&D labs and manufacturing sites allow us to deliver innovative products that lead to success for our partners.
This encompasses all projects that improve standard-of-care treatment outcomes, including cutting-edge technologies and revolutionary therapeutic approaches, while also incrementally adding value to the existing portfolio.
Should you have any CMC or manufacturing challenge, which you would like to submit to Doppel, please compile the fields below.
One of our experts will take contact with you soon to provide an overview of what we can offer.
Established in 1994, Doppel is today recognized as one of Europe’s leading experts in contract R&D and manufacturing. It has start-of-the-art facilities and highest scientific capabilities to service its international pharmaceutical and nutritional clients.